Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: The national South African prevention of mother to child evaluation cohort study
Loading...
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
BMC
Abstract
Background: The relationship between in-utero antiretroviral (ARV) drug exposure and child growth needs further study as current data provide mixed messages. We compared postnatal growth in the first 18-months of life between children who are HIV-exposed uninfected (CHEU) with fetal exposure to ARV drugs (prophylaxis or triple-drug therapy (ART)) and CHEU not exposed to ARVs. We also examined other independent predictors of postnatal growth.
Description
Keywords
HIV, South Africa, Child growth, Public health, Antenatal antiretroviral drug
Citation
Vundli, R. et al. (2022). Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study. BMC Infectious Diseases, 22(1), pp.1-14. https://doi.org/10.1186/s12879-022-07847-9